Netherlands· NL-0a57b3f617a8
Lambutrix 4 mg/ml, oplossing voor injectie
A lorazepam product containing lorazepam, registered in Netherlands by Macure Healthcare Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Lorazepam is registered in 16 of 19 countries.
Countries holding a registration under ATC N05BA06 (lorazepam), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Lorazepam · ATC N05BA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lorazepam costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.084 in France to $0.81 in Switzerland — a ×9.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lorazepam · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.81
- ES Spain$0.16
- FR France$0.084
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LORAZEPAM
- Manufacturer
- Macure Healthcare Limited
- Country
- Netherlands (NL)
- ATC code
- N05BA06
- ATC class
- Lorazepam
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id127548
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
413 interactions on record for lorazepam.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lorazepam · interactions on record
413 records
- 4 severe
- 70 moderate
- 22 minor
- 266 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
51 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lorazepam in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceLORAZEPAM XILMAC 4 mg/mL, solution injectableMACURE HEALTHCARE (MALTE)
- United StatesAtivanHikma Pharmaceuticals USA Inc.
- United KingdomAtivan 4mg/1ml solution for injection ampoulesPfizer Ltd
- CzechiaTEMELORMedochemie Ltd., Limassol
- SwitzerlandLorazepam axapharm 1 mg, Tablettenaxapharm ag
- BelgiumLambutrix 4 mg/mlMacure Healthcare
- SpainLORAZEPAM ARISTO 1 MG COMPRIMIDOS BUCODISPERSABLES EFGAristo Pharma Gmbh
- CanadaAPO-LORAZEPAMAPOTEX INC
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Lorazepam Macure, Temesta
- Belgium · Lambutrix, Lorazepam Ab
- Bulgaria · Лоразепам Tzf, Лорапам
- Cyprus · Lorans, Lorivan
- Czechia · Temelor
- Germany · Lorazepam Aristo, Lorazepam Dura
- Denmark · Lorazepam Macure, Lorazepam Orion
- Estonia · Lorans, Temelor
- Spain · Lorazepam Aurovitas, Lorazepam Cinfa
- Finland · Lorazepam Macure, Lorazepam Orion
- France · Lorazepam Arrow, Lorazepam Viatris
- United Kingdom (Northern Ireland) · Lorazepam, Lorazepam Alissa Healthcare Research
- Greece · Akivass, Dorm
- Croatia · Lorsilan, Temelor
- Hungary · Loranxil, Lorazepam Orion
- Ireland · Ativan, Lorazepam Aspire Pharma (Malta)
- Italy · Control, Lorans
- Lithuania · Dalixen, Lirezid
- Luxembourg · Lambutrix, Lorazepam Eg
- Latvia · Lorafen, Lorazepam Macure
- Malta · Ativan, Lorivan
- Norway · Lorazepam Macure, Rativor
- Poland · Lorabex, Lorafen
- Portugal · Ansilor, Lorazepam Aristo
- Romania · Anxiar, Temelor
- Sweden · Lorazepam Macure, Lorazepam Orion
- Slovenia · Lorazepam Macure, Lorsilan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bed31731-82cb-42dd-99d3-9cd6e4c398ce GET /v1/drugs/bed31731-82cb-42dd-99d3-9cd6e4c398ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Intraveneus gebruik, Intramusculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127548_smpc_en.pdf",
"strength": null,
"atc_label": "Lorazepam",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127548",
"excipients": [
"BENZYLALCOHOL (E 1519)",
"MACROGOL 400",
"PROPYLEENGLYCOL (E 1520)",
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"LORAZEPAM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127548_piluk.pdf",
"authorised_at": "2022/01/05",
"procedure_number": "NL/H/5225/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "127548",
"additional_monitoring": "N"
}See everything about lorazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.